The Streptomycin-Treated Mouse Intestine Selects \u3cem\u3eEscherichia coli envZ\u3c/em\u3e Missense Mutants That Interact with Dense and Diverse Intestinal Microbiota by Leatham-Jensen, Mary P. et al.
University of Rhode Island
DigitalCommons@URI
Cell and Molecular Biology Faculty Publications Cell and Molecular Biology
2012
The Streptomycin-Treated Mouse Intestine Selects
Escherichia coli envZ Missense Mutants That Interact
with Dense and Diverse Intestinal Microbiota
Mary P. Leatham-Jensen
University of Rhode Island
Jakob Frimodt-Møller
See next page for additional authors
Follow this and additional works at: https://digitalcommons.uri.edu/cmb_facpubs
Terms of Use
All rights reserved under copyright.
This Article is brought to you for free and open access by the Cell and Molecular Biology at DigitalCommons@URI. It has been accepted for inclusion
in Cell and Molecular Biology Faculty Publications by an authorized administrator of DigitalCommons@URI. For more information, please contact
digitalcommons@etal.uri.edu.
Citation/Publisher Attribution
Leatham-Jensen, M. P., Frimodt-Møller, J., Adediran, J., Mokszycki, M. E., Banner, M. E., Caughron, J. E.,...Cohen, P. S. (2012). The
Streptomycin-Treated Mouse Intestine Selects Escherichia coli envZ Missense Mutants That Interact with Dense and Diverse Intestinal
Microbiota. Infection and Immunity,80(5), 1716-1727. doi: 10.1128/IAI.06193-11
Available at: http://dx.doi.org/10.1128/IAI.06193-11
Authors
Mary P. Leatham-Jensen, Jakob Frimodt-Møller, Jimmy Adediran, Matthew E. Mokszycki, Megan E. Banner,
Joyce E. Caughron, Karen A. Krogfelt, Tyrrell Conway, and Paul S. Cohen
This article is available at DigitalCommons@URI: https://digitalcommons.uri.edu/cmb_facpubs/74
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Intestinal Microbiota
Mary P. Leatham-Jensen,a Jakob Frimodt-Møller,b Jimmy Adediran,a Matthew E. Mokszycki,a Megan E. Banner,a Joyce E. Caughron,c
Karen A. Krogfelt,b Tyrrell Conway,c and Paul S. Cohena
Department of Cell and Molecular Biology, University of Rhode Island, Kingston, Rhode Island, USAa; Department of Microbiological Surveillance and Research, Statens
Serum Institut, Copenhagen S, Denmarkb; and Department of Botany and Microbiology, University of Oklahoma, Norman, Okloahoma, USAc
Previously, we reported that the streptomycin-treated mouse intestine selected nonmotile Escherichia coli MG1655 flhDC dele-
tion mutants of E. coli MG1655 with improved colonizing ability that grow 15% faster in vitro in mouse cecal mucus and 15 to
30% faster on sugars present in mucus (M. P. Leatham et al., Infect. Immun. 73:8039 – 8049, 2005). Here, we report that the 10 to
20% remaining motile E. coli MG1655 are envZ missense mutants that are also better colonizers of the mouse intestine than E.
coli MG1655. One of the flhDC mutants, E. coli MG1655flhD, and one of the envZ missense mutants, E. coli MG1655 mot-1,
were studied further. E. coli MG1655 mot-1 is more resistant to bile salts and colicin V than E. coli MG1655flhD and grows ca.
15% slower in vitro in mouse cecal mucus and on several sugars present in mucus compared to E. coli MG1655flhD but grows
30% faster on galactose. Moreover, E. coli MG1655 mot-1 and E. coli MG1655flhD appear to colonize equally well in one intes-
tinal niche, but E. coli MG1655 mot-1 appears to use galactose to colonize a second, smaller intestinal niche either not colonized
or colonized poorly by E. coli MG1655flhD. Evidence is also presented that E. coli MG1655 is a minority member of mixed bac-
terial biofilms in the mucus layer of the streptomycin-treated mouse intestine. We offer a hypothesis, which we call the “Restau-
rant” hypothesis, that explains how nutrient acquisition in different biofilms comprised of different anaerobes can account for
our results.
When a bacterial species indefinitely persists in stable num-bers in the intestine of an animal, without repeated intro-
duction, the animal is, by definition, colonized by the bacterium.
Commensal Escherichia coli strains colonize the human intestine
in the presence of a dense and diverse intestinal microbiota com-
prised of at least 500 cultivable species and 1013 to 1014 total bac-
teria (15). Unfortunately, E. coli colonization cannot be studied
experimentally in conventional animals due to colonization resis-
tance, which results when all niches are filled by the microbiota
(10). Such experiments require an animalmodel with open niches
forE. coli to colonize in relatively high numbers butmust also have
a dense and diverse anaerobic community that matches as closely
as possible the native microbiota of the conventional animal. The
streptomycin-treated mouse model is used routinely for this pur-
pose (11, 34).
In mammals, a large fraction of the intestinal microbiota be-
longs to either of two phyla, the Firmicutes and the Bacteroidetes
(16, 37, 58). Extensive microbiological characterization of themi-
crobial community in the streptomycin-treated mouse intestine,
published in the classic paper byHentges et al. (28), demonstrated
that streptomycin treatment (5 mg/ml in drinking water) selec-
tively removes the facultative anaerobes, withmuch less impact on
the anaerobes. Streptomycin treatment does not alter the total
numbers of Bacteroides (Bacteroidetes), Eubacterium (Firmicutes),
Bifidobacterium (Actinobacteria), andClostridium (Firmicutes), al-
though there is a large decrease in Lactobacillus (Firmicutes) and
Actinomyces (Actinobacteria) with a corresponding increase in
Fusobacterium (Fusobacteria) and an apparent 50% decline in an-
aerobic species, as indicated by anaerobic colony morphologies
(28). In general, more recent studies using 16S rRNA gene se-
quencing confirmed these results (23, 58, 68). It is now clear that
any strategy to overcome colonization resistance will impact com-
munity structure (12, 57). While the streptomycin-treated mouse
model is not perfect, it allows competition of a variety of E. coli
strains against a dense and diverse anaerobe population over ex-
tended time periods.
Previously, we found that when E. coli MG1655 was fed to
streptomycin-treated mice, 80 to 90% of the population lacked
flagella and became nonmotile within 7 to 9 days postfeeding (24,
36). We showed that these nonmotile better colonizing mutants
have deletions of various sizes beginning downstream of an IS1
element in the flhDC regulatory region and extending into or be-
yond the flhDC structural genes (24, 36). FlhD and FlhC form the
FlhD4C2 complex (5, 40, 66), which activates transcription of class
II flagellar genes that encode components of the flagellar basal
body and exportmachinery (51). The IS1 element upstreamof the
E. coliMG1655 flhDC promoter increases expression of the flhDC
operon and makes E. coliMG1655 hypermotile (4, 24).
The flhDC deletion mutants selected by the streptomycin-
treated mouse intestine were found to grow faster than the parent
strain in vitro inmouse cecalmucus and on sugars normally found
in the mucus layer of the intestine (24, 36), which presumably
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explains why they were selected. Additional studies suggested the
E. coliMG1655 flhDC operon deletion mutants utilize sugars bet-
ter than their parent because a number of metabolic genes are
repressed by the FlhD4C2 regulatory complex, including gltA
(citrate synthase), sdhCDAB (succinate dehydrogenase), mdh
(malate dehydrogenase), mglBAC (galactose transport), and a
large number of sugar catabolism operons (20, 52, 53). Also, in-
creased energy is available for other cellular processes in the ab-
sence of hyper-flagellum synthesis and rotation (24).
Despite the strong selection for nonmotile E. coli MG1655
flhDC deletionmutants by the streptomycin-treatedmouse intes-
tine, 10 to 20% of the E. coli MG1655 remained motile over a 15
day period (24), suggesting either that they too were better colo-
nizing mutants or that an as-yet-undefined intestinal niche exists
in which motility is an advantage. Here, we report that the 10 to
20% of E. coli MG1655 that remain motile in the streptomycin-
treated mouse intestine are envZ missense mutants that display
increased colonizing ability.
MATERIALS AND METHODS
Bacterial strains. Bacterial strains used in the present study are listed in
Table 1. The original E. coli strain K-12 was obtained from a stool sample
from a convalescing diphtheria patient in Palo Alto, CA, in 1922 (2). The
sequenced E. coliMG1655 strain (CGSC 7740) was derived from the orig-
inal K-12 strain, having only been cured of the temperate bacteriophage
lambda and the F plasmid by means of UV light and acridine orange
treatment (2). It has an IS1 element in the flhDC promoter (6). The E. coli
MG1655-IS1 strain used in the present investigation is isogenic to the
MG1655 strain but lacks the IS1 element in the flhDC promoter (24). The
allelic-exchange method described by Datsenko and Warner (13) was
used to construct E. coli MG1655 galK, which contains a 912-bp dele-
tion, replaced by a chloramphenicol cassette beginning 153 bp down-
stream of the ATG start codon and ending 78 bp upstream of the TGA
stop codon. As expected, the E. coliMG1655 mot-1 galK strain failed to
grow in M9 minimal medium containing 0.4% (wt/vol) galactose as the
sole carbon and energy source. E. coliMG1655 mot-1 galK was restored
to Gal by allelic replacement (13), selecting for restored growth on M9
minimal galactose agar plates. The restored Gal E. coli MG1655 mot-1
grew at the same rate as E. coli MG1655 mot-1 in M9 galactose minimal
medium. The mutated envZ gene in E. coli MG1655 mot-1 was replaced
with the wild-type envZ gene using an unpublished allelic replacement
strategy developed by Barry Wanner and Kiryl Datsenko at Purdue Uni-
versity (unpublished data). The first step replaced the E. coli MG1655
mot-1 envZ/ompR locus with a cassette encoding kanamycin resistance
(kan) and parE under the control of the rhamnose promoter (kan-rhaP-
parE). The parE gene encodes a DNA gyrase inhibitor, i.e., the toxin of a
toxin anti/toxin pair that kills the cell when produced in the absence of its
cognate antitoxin (31). The second step replaced the kan-rhaP-parE cas-
sette with the wild-type envZ allele by selecting for growth onM9minimal
agar plates containing 1.0% (wt/vol) rhamnose (which would otherwise
kill when rhamnose induces ParE). The double recombination event
leaves no scars on the genome. All constructions were confirmed by se-
quencing.
Media and growth conditions. LB broth Lennox (Difco Laboratories,
Detroit, MI), LB agar Lennox (Difco), andMacConkey agar (Difco) were
used for routine cultivation. SOC medium was prepared as described by
Datsenko andWanner (13). For testing carbon and energy source utiliza-
tion, M9 minimal medium (44) was modified by addition of 120 mM
NaCl to more closely approximate the sodium chloride concentration in
the intestine (3). Growth also was tested in cecal mucus (2.5 mg of pro-
tein/ml) inHEPES-Hanks buffer (pH 7.0), which contains 137mMNaCl,
the sodium chloride concentration in jejunal and ileal intestinal fluid (3).
Cultures were prepared, and growth was monitored as described previ-
ously (36).
Isolation of cecal mucus. Mouse cecal mucus was isolated as previ-
ously described (9). Briefly,mice (5 to 8weeks old)were fedTekladmouse
and rat diet (Harlan Laboratories, Madison, WI) for 5 days after being
received. The drinking water was then replaced with sterile distilled water
containing streptomycin sulfate (5 g/liter). After 24 h, the mice were sac-
rificed by CO2 asphyxiation, and their ceca were removed. The cecal con-
tents were washed out with sterile distilled water, and the cecal mucus was
scraped intoHEPES-Hanks buffer (pH 7.0), centrifuged, and sterilized by
UV irradiation as described previously (9). All animal protocols were
TABLE 1 Bacterial strains
E. coli strain Genotype and/or phenotypea Abbreviated form
Source or
reference
MG1655 Strr Spontaneous streptomycin resistant mutant of MG1655 MG1655 45
MG1655 Strr flhD::cat 546-bp deletion beginning immediately downstream of IS1 in
the regulatory region of flhD and ending in flhD,
streptomycin and chloramphenicol resistant
MG1655 flhD 36
MG1655-IS1 Strr Nalr Spontaneous nalidixic acid-resistant mutant of MG1655 -IS1
Strr, no IS1 element in the flhDC promoter
MG1655-IS1 24
MG1655 Strr mot-1 P41L envZmissense mutant of MG1655 Strr MG1655 mot-1 This study
MG1655 Strr mot-2 P148S envZmissense mutant of MG1655 Strr MG1655 mot-2 This study
MG1655 Strr mot-3 V33E envZmissense mutant of MG1655 Strr MG1655 mot-3 This study
MG1655 Strr Nalr mot-1 Spontaneous nalidixic acid-resistant mutant of MG1655 Strr
mot-1
MG1655 mot-1 This study
MG1655 Strr Nalr mot-1 restored MG1655 Strr mot-1 restored to wild type with respect to EnvZ MG1655 mot-1 restored This study
MG1655 Strr Nalr mot-1 galK::cat 912-bp deletion in galactokinase gene replaced by a
chloramphenicol resistance cassette
MG1655 mot-1 galK This study
MG1655 Strr Nalr mot-1 galK::cat
restored
MG1655 Strr Nalr mot-1 galK::cat restored to wild type with
respect to galK
MG1655 mot-1 galK restored
to wild type with respect to
galK
This study
F-18 Strr Rifr Spontaneous streptomycin- and nalidixic acid-resistant
mutant of F-18
F-18 47
BW37751(pKD267)::Knr The plasmid in this strain contains parE under the control of
the rhamnose promoter and the kanamycin resistance gene
pKD267 Barry Wanner
a Strr, streptomycin resistance; Knr, kanamycin resistance; Nalr, nalidixic acid resistance; Rifr, rifampin resistance.
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approved by the University Committee onUse and Care of Animals at the
University of Rhode Island.
Motility. Themotility of E. coliMG1655 strains was assayed by tooth-
picking colonies from LB agar Lennox onto Luria motility agar (3.5 g/li-
ter) containing 200 mM NaCl (3). The plates were incubated for 6 h at
37°C, after which spreading was measured from the edge of each colony.
For testing the motility of fecal isolates, 50 colonies from fecal platings of
each mouse were toothpicked to motility agar made from LB broth Len-
nox containing 85.5 mM NaCl. The plates were incubated overnight at
room temperature. For testing motility of bacteria from intestinal seg-
ments, the ileum, cecum, and colon were removed from each mouse and
washed extensively with HEPES-Hanks buffer (pH 7.0), and the mucus
was scraped into 5 ml of HEPES-Hanks buffer (pH 7.0), as described
previously (9). Samples were homogenized by vortexing, plated on Mac-
Conkey agar with appropriate antibiotics, and toothpicked onto motility
agar, as described above for fecal isolates.
Growth in the presence of 5% bile salts. Strains to be tested for bile
sensitivity were grown overnight in LB broth Lennox, diluted to anA600 of
0.1 into fresh LB broth Lennox containing 5% (wt/vol) Bacto-Bile Salts
No. 3 (Difco Laboratories), and incubated at 37°Cwith shaking in 125-ml
tissue culture bottles.
Mouse colonization experiments. The specifics of the streptomycin-
treated mouse model used to compare the large intestine colonizing abil-
ities ofE. coli strains inmice have been described previously (42, 47, 59, 60,
65). Briefly, sets of three male CD-1 mice (5 to 8 weeks old) were given
drinkingwater containing streptomycin sulfate (5 g/liter) for 24 h to elim-
inate resident facultative bacteria (43). After 18 h of starvation for food
and water, the mice were fed 1 ml of 20% (wt/vol) sucrose containing 105
CFUor 1010CFUof LBbroth Lennox-grownE. coli strains, as described in
Results. After ingesting the bacterial suspension, both the food (Teklad
mouse and rat diet; Harlan Laboratories) and streptomycin-water were
returned to the mice, and 1 g of feces was collected after 5 h, 24 h, and on
odd-numbered days thereafter at the indicated times. Mice were housed
individually in cages without bedding and were placed in clean cages at
24-h intervals. Individual fecal pellets were therefore no older than 24 h.
Each fecal sample (1 g) was homogenized in 10 ml of 1% Bacto tryptone
(Difco), diluted in the same medium, and plated on MacConkey agar
plates with appropriate antibiotics. When appropriate, 1 ml of a fecal
homogenate (sampled after the feces had settled) was centrifuged at
12,000 g, resuspended in 100 l of 1% Bacto tryptone, and plated on a
MacConkey agar plate with the appropriate antibiotics. This procedure
increases the sensitivity of the assay from 102 CFU/gram of feces to 10
CFU/per g of feces. To distinguish the various E. coli strains in feces,
dilutions were plated on lactose MacConkey agar containing either strep-
tomycin sulfate (100 g/ml), streptomycin sulfate (100 g/ml) and nali-
dixic acid (50 g/ml), or streptomycin sulfate (100 g/ml) and chloram-
phenicol (30 g/ml). Streptomycin sulfate, chloramphenicol, and
nalidixic acid were purchased from Sigma-Aldrich (St. Louis, MO). All
plates were incubated for 18 to 24 h at 37°C prior to counting. When
necessary to distinguish strains, 100 colonies fromplates containing strep-
tomycin were toothpicked ontoMacConkey agar plates containing strep-
tomycin and nalidixic acid or onto MacConkey agar plates containing
streptomycin and chloramphenicol. Each colonization experiment was
performed at least twice, with essentially identical results. Pooled data
from at least two independent experiments (a total of six mice) are pre-
sented in the figures.
Sequencing. DNA sequencing was done at the URI Genomics and
Sequencing Center, University of Rhode Island, Kingston, using an Ap-
plied Biosystems 3130xl genetic analyzer (Applied Biosystems, Foster City
CA). A BigDye Terminator v3.1 cycle sequencing kit (Applied Biosys-
tems) was used in the sequencing reactions. The primers used to amplify
the PCR product (2,241 bp) for sequencing the ompB locus included the
forward primer (upstream of ompR) 5=-TAGCTGGTGACGAACGTGA
G-3= and the reverse primer (downstream of envZ) 5=-GTAGCGGCTGG
TCCGAA-3=. The same primers, as well as 5=-ATCCTGCTCGCTCATCA
TC-3=, which begins 565 bp from the 3= end of envZ, were used in the
sequencing reactions. The primers used for both amplifying the galK de-
letion for allelic exchange and for sequencing to confirm its presence in E.
coliMG1655mot-1galKwere the forward primer (43 bpupstreamof the
galK coding sequence) 5=-AACAGGCAGCAGAGCGTTTGC-3= and the
reverse primer (53 bp downstream of the galK coding sequence) 5=-AGT
CCATCAGCGTGACTACCATC-3=. The primers used for the replace-
ment of the galK mutation with wild type were the forward primer (44
bp upstream of the galK start codon) 5=-AACAGGCAGCAGAGCGTTT
GC-3= and the reverse primer (68 bp downstream of the galK stop codon)
5=-AGTCCATCAGCGTGACTACCATC-3=. The primers used for con-
firming the restoration of thewild-type galK gene sequence are the same as
those used for restoring the wild-type sequence.
Colicin V sensitivity. E. coli F-18 produces colicin V (42). E. coli
MG1655 strains to be tested for sensitivity to colicin V were grown over-
night in LB broth Lennox at 37°C with shaking in 125-ml tissue culture
bottles. The next day, 106CFUof each strain to be testedwas added to 3ml
of Luria broth Lennox containing 7 g Difco agar (soft agar)/liter, which
was thenpoured onto a 20-ml Luria broth Lennox agar plate. After the soft
agar on each plate solidified, E. coli F-18 colonies were toothpicked onto
each plate and incubated for 18 h at 37°C, and zones of growth inhibition
were measured.
Fluorescence in situ hybridization. The preparation of mouse cecal
histological sections, the oligonucleotide probes, hybridization, and con-
focal microscopy were all as described previously (46).
Statistics. Means derived from the indicated number of samples were
compared by using the Student t test (P values). A P value of 0.05 was
interpreted as indicating no significant difference, and a P value of0.05
was interpreted as indicating a significant difference.
RESULTS
Isolation of E. coli MG1655 mot-1, mot-2, and mot-3 from the
mouse intestine. Previously, we showed that despite the strong
selection for nonmotile E. coliMG1655 flhDC deletionmutants by
the streptomycin-treated mouse intestine, 10 to 20% of the E. coli
MG1655 cells remained motile over a 15-day period (36). To de-
termine the nature of the population that remained motile, three
mice were fed 1010 CFU of E. coliMG1655 and 105 CFU of E. coli
MG1655 flhD. At 5 h and day 1 postfeeding, the level of E. coli
MG1655flhD in feces was5 orders ofmagnitude lower than E.
coli MG1655, but by day 7 E. coli MG1655 flhD had grown to a
population of only 1.5 orders of magnitude lower than E. coli
MG1655 and remained at that level thereafter for the 15 days of
the experiment (Fig. 1A). As a control, mice were fed 1010 CFU of
E. coli MG1655 flhD and 105 CFU of E. coli MG1655. As ex-
pected, the better colonizing E. coli MG1655 flhD completely
eliminated E. coliMG1655 within 3 days postfeeding (Fig. 1B). At
day 15, the mice fed high numbers of E. coli MG1655 and low
numbers of E. coli MG1655 flhD (Fig. 1A) were sacrificed, and
the numbers of E. coliMG1655 and E. coliMG1655 flhD in ileal
mucus, cecal mucus, and colonicmucus were determined. In each
mucus preparation, the numbers of E. coli MG1655 flhD were
1.5 to 2 orders of magnitude lower than E. coliMG1655, reflecting
the results observed in feces (Table 2). Although less than 1 in
6,300 CFU of the E. coli MG1655 fed to the mice were nonmotile
(24) and less than 1 in 100 CFU in feces were nonmotile at both 5
h and 1 day postfeeding, by day 3 postfeeding 17%  7.9%
(mean the SEM) in feces were nonmotile, by day 7 postfeeding
65%  15% in feces were nonmotile, by day 13 postfeeding
75%  18% in feces were nonmotile, and on day 15 postfeed-
ing 76% 13% in feces were nonmotile. Therefore, despite com-
petition from the better-colonizing E. coliMG1655flhD and the
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selection by the intestine of nonmotile E. coliMG1655, ca. 25% of
the E. coli MG1655 remained motile within each section of the
intestine. On day 13 postfeeding, 1 motile E. coliMG1655 colony
was selected from the feces of eachmouse for further study. These
strains were designated E. coliMG1655mot-1, mot-2, andmot-3,
respectively.
E. coli MG1655 mot-1, mot-2, and mot-3 are envZ missense
mutants. E. coliMG1655 mot-1, mot-2, and mot-3 were less mo-
tile than the hypermotile E. coliMG1655 (Table 3). Previously, we
reported that when the IS1 element was removed from the flhDC
regulatory region of E. coli MG1655, the resulting strain, E. coli
MG1655-IS1, was a better colonizer and remained motile, al-
though far less so than its parent (24). However, E. coli MG1655
mot-1, mot-2, andmot-3 retained the IS1 element, as determined
by PCR (data not shown).
Giraud et al. reported that when germfree mice were fed E. coli
MG1655, themouse intestine selected better-colonizing, less-mo-
tile E. coliMG1655mutants that contained pointmutations in the
envZ-ompR locus (25). EnvZ, a histidine kinase, and OmpR, its
cognate response regulator, comprise a two-component signal
transduction system that modulates gene expression in response
to osmolarity (17). When we sequenced the envZ and ompR genes
of the threemotmutants—E. coliMG1655flhD,E. coliMG1655-
IS1, and E. coli MG1655—we found that the ompR sequences of
the six strains were identical, as were the envZ sequences of E. coli
MG1655 flhD, E. coli MG165-IS1, and the wild-type E. coli
MG1655. Importantly, E. coli MG1655 mot-1, mot-2, and mot-3
were found to be envZ missense mutants: mot-1 a P41L mutant
(CCG to CTG) in the N-terminal transmembrane domain, mot-2
a P148S mutant (CCG to TCG) in the periplasmic osmolarity
sensing domain, and mot-3 a V33E mutant (GTG to GAG) in
the N-terminal transmembrane domain (21, 69). That the envZ
missense mutation in mot-1 was responsible for reduced mo-
tility was shown by the fact that when E. coli MG1655 mot-1
was restored to the wild type with respect to envZ, it regained
hypermotility (Table 3).
The E. coli mot mutants are resistant to bile salts and colicin
V. Among the many activities controlled by the two component
EnvZ/OmpR signal transduction system are transcription of
ompF and ompC, which encode E. coli outer membrane porins
that allow passage of many small molecules (600 Da) from the
environment into the periplasm (1). Bile salts, which are present
in the human small intestine at a concentration of ca. 0.3% (64)
and can inhibit E. coli growth at 5% concentration in vitro (25),
pass readily through theOmpFporin butmuch less so through the
OmpC porin (62). High levels of OmpRP downregulate tran-
FIG 1 Colonizationof themouse intestine byE. coliMG1655 andE. coliMG1655
flhD. Three mice were fed 1010 CFU of E. coliMG1655 Strr (Œ) and 105 CFU of
MG1655 Strr flhD::cat () (A), and three mice were fed 1010 CFU of MG1655
Strr flhD::cat () and 105 CFU of MG1655 Strr Nalr (Œ) (B). At the indicated
times, fecal samples were homogenized, diluted, and plated as described inMate-
rials andMethods.Bars representing standarderrorsof the log10meansofCFUper
g of feces for three mice are presented for each time point.
TABLE 2 E. coli MG1655 and E. coli MG1655 flhD and percent
nonmotile E. coliMG1655 in mouse ileal, cecal, and colonic mucosa at
15 days postfeeding
Location







Ileal mucus 4.81 0.57 3.37 0.41 75 14
Cecal mucus 7.15 0.27 5.26 0.57 83 7.9
Colonic mucus 6.73 0.27 4.63 0.82 72 11
Feces 8.39 0.07 6.58 0.19 76 13
a The values are means for three mice. Mucus preparations were isolated on day 15
postfeeding. The CFU values for the mucus preparations are corrected for the entire
volume of each mucus preparation. The fecal values are the CFU/g of feces at 15 days
after feeding.
b A total of 50 E. coliMG1655 colonies isolated from the 15-day mucuspreparations and
feces of each of the three mice were tested for motility asdescribed in Materials and
Methods. The values are means for three mice.
TABLE 3Motility of E. coli MG1655 strains
E. coli strain
Mean spread (mm) SEM (P)a
Expt 1 Expt 2
MG1655 8.3 0.4 9.6 0.2
MG1655 flhD 0 0
MG1655-IS1 1.8 0.4 (0.005) 1.6 0.3 (0.001)
MG1655 mot-1 3.7 0.4 (0.005) 3.1 0.4 (0.002)
MG1655 mot-1 restored
to wild type
ND 8.8 0.3 (0.05)
MG1655 mot-2 3.7 0.7 (0.005) ND
MG1655 mot-3 4.4 0.8 (0.01) ND
a That is, the spread of E. coliMG1655 strains on Luria motility agar containing 200
mM NaCl after 6 h at 37°C as described in Materials and Methods. Values represent the
means of three samples. P values, determined using the Student t test and indicated in
parentheses, were calculated for each strain relative to E. coliMG1655 in the same
experiment. ND, not done.
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scription of ompF and upregulate transcription of ompC, resulting
in decreased OmpF and increased OmpC in the outer membrane
(55). The E. coli MG1655 envZ missense mutants described by
Girard et al. as being selected in germfree mice monoassociated
with E. coli MG1655 were reported to have decreased OmpF and
increased OmpC and were found to be more resistant to 5% bile
salts than their parent (25), suggesting that the envZmutants had
higher levels of OmpRP than E. coli MG1655. Here, we report
that E. coli MG1655 mot-1, mot-2, and mot-3 are far more resis-
tant to 5% bile salts than E. coli MG1655, E. coli MG1655 flhD,
and an E. coliMG1655 mot-1 strain restored to wild type (Fig. 2A
and 2B). It should also be noted that the E. coliMG1655 and E. coli
MG1655 flhD strains are still relatively resistant to bile salts, i.e.,
their growth is unaffected by 0.3% bile salts (data not shown), the
concentration reported to be present in the human small intestine
(64).
In addition to regulating ompF and ompC, the EnvZ/OmpR
signal transduction system also positively regulates the transcrip-
tion of omrA and omrB, which encode two small RNAs that neg-
atively regulate the expression of a number of outer membrane
proteins, including CirA, the receptor for colicin V (7). Since it
appeared likely that the E. coliMG1655 mot mutants have higher
than normal levels of OmpRP, it seemed possible that they
would have lower levels of CirA in the outermembrane and there-
fore be more resistant to the action of colicin V. Indeed, E. coli
F-18, which produces colicin V (44), inhibited the growth of E.
coliMG1655 (zone of inhibition, 2.01 0.11 mm [n 8]), E. coli
MG1655flhD (zone of inhibition, 2.03 0.11mm [n 8]), and
E. coli MG1655 mot-1 restored to wild type (zone of inhibition,
1.98 0.21 mm [n 8]) to a greater extent than it inhibited the
growth of E. coli MG1655 mot-1 (zone of inhibition, 0.40 0.07
mm [n  8]), E. coli MG1655 mot-2 (zone of inhibition, 0.53 
0.13 mm [n 8]), and E. coliMG1655 mot-3 (zone of inhibition,
0.31  0.08 mm [n  8]) (P  0.0005 in each case), suggesting
that themotmutants have less-than-normal levels of CirA in their
outer membranes. Furthermore, since omrA and omrB also nega-
tively regulate expression of a number of other outer membrane
proteins (26), such as CsgD (regulator of Curli biosynthesis), it is
likely that the outer membranes of the E. coli MG1655 mot mu-
tants differ markedly from those of E. coli MG1655 and E. coli
MG1655 flhD.
E. coli MG1655 mot-1 is a better mouse intestinal colonizer
than E. coli MG1655 and equal to E. coli MG1655 flhD. The
P41L replacement in EnvZ previously was shown to result in
higher than normal levels of OmpRP in E. coli AT142 (63). We
therefore chose to studyE. coliMG1655mot-1 inmore detail since
it has the same envZmissense mutation. We found that when 105
CFU each of E. coliMG1655mot-1 and E. coliMG1655were fed to
mice simultaneously, E. coliMG1655mot-1 colonized at a level of
109 CFU per g of feces, whereas E. coli MG1655 colonized at a
level of between 105 and 106 CFU per g of feces (Fig. 3A). The
enhanced colonization of E. coliMG1655 mot-1 could be specifi-
cally attributed to the P41L replacement in EnvZ, since E. coli
MG1655 mot-1 restored to wild type and E. coliMG1655 cocolo-
nized at equal population sizes (data not shown).Moreover,E. coli
MG1655 mot-1 was as good a colonizer as E. coli MG1655 flhD
(Fig. 3B). Therefore, E. coliMG1655mot-1 is a far better colonizer
than E. coli MG1655 wild type and as competitive as E. coli
MG1655 flhD, which explains why the mot-1 strain can remain
in the intestine at high levels despite conversion of the majority of
the wild-type E. coliMG1655 to theflhD genotype with its supe-
rior colonization phenotype.
Growth of E. coli MG1655 mot-1 on sugars in vitro. To ad-
dress the question of whether E. coli MG1655 mot-1 and E. coli
MG1655 flhD are equally good colonizers because they grow
equally well on sugars present in themouse intestine, experiments
were performed to compare the growth rates of E. coli MG1655
mot-1, E. coliMG1655 flhD, and E. coliMG1655 on a variety of
sugars as the sole source of carbon and energy. E. coli MG1655
mot-1 and E. coliMG1655 flhD did not grow equally well on all
of the sugars tested. In fact, E. coliMG1655mot-1 grew 30% faster
than E. coli MG1655 flhD on galactose (P  0.0005) and 5%
faster onN-acetylglucosamine (P 0.01) but grew slower than E.
coliMG1655 flhD on arabinose (15%, P 0.005), fucose (14%,
P 0.01), glucose (10%,P 0.01),maltose (27%,P 0.001), and
mannose (5%, P 0.025) and at the same rate as E. coliMG1655
flhDon fructose (P 0.15), gluconate (P 0.2), and ribose (P
0.05) (Table 4). Also, E. coliMG1655mot-1 grew faster than E. coli
MG1655 on fructose (16%, P  0.01), galactose (34%, P 
0.0005), gluconate (11%, P  0.005), mannose (9%, P  0.05),
and N-acetylglucosamine (21%, P  0.001), slower than E. coli
FIG2 Growth ofE. coliMG1655 strains in the presence of 5%bile salts. (A and
B) E. coli MG1655 Strr (), E. coli MG1655 mot-1 Strr (), E. coli MG1655
mot-2 Strr (Œ),E. coliMG1655mot-3 Strr (o), andE. coliMG1655 StrrflhD::
cat (Œ) (A) and E. coliMG1655 Strr (Œ), E. coliMG1655mot-1 Strr (), and E.
coli MG1655 mot-1 Strr restored to wild type () (B) in Luria broth Lennox
containing 5% bile salts (wt/vol). Incubation was at 37°C with aeration. The
means and standard deviations of the A600 values at the indicated times are
presented for three independent cultures of each strain.
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MG1655 on maltose (12%, P 0.005), and at the same rate as E.
coliMG1655 on arabinose (P 0.10), fucose (P 0.10), glucose
(P  0.05), and ribose (P  0.05) (Table 4). In addition, E. coli
MG1655 flhD grew 4 to18% faster than E. coliMG1655 on all of
the sugars tested as the sole carbon and energy sources (P 0.01
to  0.0005 depending on the sugar) except for galactose, on
which the two strains grew equally well (P 0.15) (Table 4). That
the 34% faster growth rate of E. coli MG1655 mot-1 on galactose
relative to wild-type E. coliMG1655was due to the P41Lmutation
in EnvZ was shown by the fact that the growth rates of E. coli
MG1655 mot-1 restored to wild type and E. coli MG1655 on ga-
lactose were identical (P 0.15) (Table 4).
Growth of E. coli MG1655 mot-1 in cecal mucus in vitro. E.
coli MG1655 simultaneously metabolizes a number of sugars
when it colonizes the streptomycin-treated mouse intestine (8,
19). That E. coliMG1655 mot-1 grew slower than E. coliMG1655
flhD on arabinose, fucose, and maltose, three sugars used by E.
coli MG1655 for growth in the mouse intestine (8, 19, 33), but
faster on galactose andN-acetylglucosamine could explain why E.
coli MG1655 mot-1 colonizes mice as well as E. coli MG1655
flhD. Since E. coli colonizes the intestine by growing in intestinal
mucus (39, 45, 46, 48, 59, 60, 65), which contains at least 13 dif-
ferent monosaccharides that can be used by E. coli, we examined
the growth rates of E. coli MG1655 mot-1, the E. coli MG1655
mot-1 strain restored to wild type, E. coli MG1655, and E. coli
MG1655 flhD in mouse cecal mucus standing cultures (2.5
mg/ml with respect to protein). Under these conditions, E. coli
MG1655 mot-1 grew ca. 15% slower than E. coli MG1655 flhD
(P  0.025) but at about the same rate as E. coli MG1655 (P 
0.15) and E. coli MG1655 mot-1 restored to wild type (P 0.50)
(Table 5). Therefore, the differences in growth rates of the strains
in cecal mucus do not reflect their relative colonizing abilities, i.e.,
E. coliMG1655 mot-1 E. coliMG1655 flhD E. coliMG1655
(Fig. 3).
E. coli MG1655 mot-1 resides in all intestinal niches occu-
pied by E. coli MG1655 flhD. Although low numbers of E. coli
MG1655 flhD grew to higher numbers in the presence of high
numbers of E. coli MG1655 in the mouse intestine (Fig. 1), it did
not grow up relative to E. coliMG1655mot-1, i.e., the two strains,
fed tomice in numbers 5 orders ofmagnitude apart, remained 5 to
FIG 3 Colonization of the mouse intestine by E. coliMG1655, E. coliMG1655
mot-1, E. coliMG1655mot-1 restored to wild type, and E. coliMG1655flhD.
Three sets of three mice were fed 105 CFU of MG1655 mot-1 Strr (Œ) and 105
CFU of E. coliMG1655 Strr Nalr () (A), and three sets of three mice were fed
105 CFU of E. coliMG1655mot-1 Strr (Œ) and 105 CFU of E. coliMG1655 Strr
flhD::cat () (B). At the indicated times, fecal samples were homogenized,
diluted, and plated as described in Materials and Methods. When necessary,
i.e., to distinguish strains, 100 colonies from plates containing streptomycin
were toothpicked onto MacConkey agar plates containing streptomycin and
nalidixic acid or onto MacConkey agar plates containing streptomycin and
chloramphenicol. Bars represent standard errors of the log10means ofCFUper
g of feces.
TABLE 4 Growth of MG1655 strains on various carbon sourcesa
Carbon source










Arabinose 98 1.0 97 0.3 83 1.2 ND ND
Fucose 115 3.1 118 1.2 102 2.9 ND ND
Fructose 139 1.8 117 3.5 114 1.2 ND ND
Galactose 204 3.5 135 1.2 201 1.2 207 1.1 NG
Gluconate 87 0.7 77 1.3 76 0.3 ND ND
Glucose 83 1.2 86 1.8 77 0.9 ND ND
Maltose 112 2.0 127 1.6 101 0.2 ND ND
Mannose 192 4.2 175 2.9 166 0.3 ND ND
NAGc 107 1.5 85 0.4 89 0.8 105 1.3 ND
Ribose 181 1.2 179 0.3 174 1.3 ND ND
a Carbon source utilization was determined in M9 minimal medium (0.4% [wt/vol]) in 125-ml tissue culture flasks with shaking. Inocula were grown on M9 glycerol (0.4% [vol/
vol]) and then overnight on the specified carbon source.
b Generation times were calculated from semilogarithmic plots. ND, not done; NG, no growth.
c NAG, N-acetylglucosamine.
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6 orders of magnitude apart throughout the 15 days of the exper-
iment (Fig. 4A). E. coliMG1655 mot-1 did not prevent low num-
bers of E. coli MG1655 flhD from growing to higher numbers
due to flhDC deletionmutants arising in theE. coliMG1655mot-1
population, since at 7 and 15 days postfeeding 50 E. coliMG1655
mot-1 colonies from each mouse were tested, and all remained
motile. Nor was it due to an inhibitor made by E. coli MG1655,
since E. coli MG1655 flhD growth was unaffected by E. coli
MG1655 mot-1 in colicin tests (data not shown). Clearly, the en-
hanced colonization of E. coliMG1655 mot-1 was due specifically
to the P41L envZmutation, since E. coliMG1655flhD grew from
low to high numbers in themouse intestine in the presence of high
numbers of E. coliMG1655 mot-1 restored to wild type (Fig. 4B).
Therefore, it is likely that high numbers of E. coliMG1655 mot-1
prevented low numbers of E. coliMG1655flhD from growing to
higher numbers because E. coli MG1655 mot-1 resides in and
competes effectively in all intestinal niches occupied by E. coli
MG1655 flhD.
E. coliMG1655 does not use galactose to colonize the strepto-
mycin-treatedmouse intestine, i.e., an E. coliMG1655galKmu-
tant that is unable to grow on galactose as a sole carbon source
cocolonizes equally well with E. coli MG1655 wild type in the
streptomycin-treated mouse intestine (19). However, it appears
that the ability of E. coli MG1655 mot-1 to grow 30% faster on
galactose than E. coliMG1655 flhD contributes in part to it pre-
venting low numbers of E. coli MG1655 flhD from growing to
higher numbers. When E. coliMG1655flhDwas fed to mice at 5
orders of magnitude lower than E. coli MG1655 mot-1 galK, it
colonized at a level 4 orders of magnitude lower (Fig. 4C), rather
than the 5 to 6 orders of magnitude lower in competition with E.
coli MG1655 mot-1 (Fig. 4A) or E. coli MG1655 mot-1 galK
restored to wild type with respect to galK (data not shown). It
should be emphasized, however, that E. coliMG1655mot-1galK
still prevented E. coli MG1655 flhD from growing to a level any
higher than 4 orders of magnitude below it, despite growing 25%
slower than E. coli MG1655 mot-1 in cecal mucus in vitro (P 
0.01) (Table 5).
E. coli MG1655 mot-1 may colonize an intestinal niche that
E. coli MG1655 flhD colonizes poorly. That E. coli MG1655
mot-1 resides in all intestinal niches occupied by E. coli MG1655
flhD does notmean E. coliMG1655flhD resides in all intestinal
niches occupied by E. coli MG1655 mot-1. Since E. coli MG1655
mot-1 andE. coliMG1655flhD are equally good colonizerswhen
105 CFU of each is fed tomice (Fig. 3C) and since high numbers of
E. coli MG1655 mot-1 prevent low numbers of E. coli MG1655
flhD from growing to high numbers in the intestinal niches they
occupy together (Fig. 4A), it would be expected that if E. coli
MG1655 flhD resides in all intestinal niches occupied by E. coli
MG1655mot-1 that high numbers ofE. coliMG1655flhDwould
prevent low numbers of E. coli MG1655 mot-1 from growing to
higher numbers in the streptomycin-treated mouse intestine. To
test that possibility, mice were fed 1010 CFU of E. coli MG1655
flhD and 105 CFU of E. coliMG1655 mot-1. Surprisingly, E. coli
MG1655 mot-1 grew from about 5 orders of magnitude lower
than E. coli MG1655 flhD to within 2 orders of magnitude of E.
coli MG1655 flhD by 9 days postfeeding (Fig. 5A). Therefore, it
appears that E. coli MG1655 mot-1 not only resides in all the
intestinal niches occupied by E. coli MG1655 flhD but may also
colonize a smaller niche that E. coli MG1655 flhD is unable to
colonize or colonizes poorly. Moreover, it appears that E. coli
MG1655 mot-1 uses its superior ability to metabolize galactose to
colonize that niche, since low numbers of E. coli MG1655 mot-1
galK failed to grow to higher numbers in the presence of high
numbers of E. coliMG1655flhD (Fig. 5B), whereas low numbers
of E. coliMG1655 mot-1 galK restored to wild type with respect
to galactose utilization grew to higher numbers (data not shown).
To summarize, E. coli MG1655 mot-1 and E. coli MG1655 flhD
appear to colonize one intestinal niche equally well and E. coli
MG1655mot-1 appears to need galactose formaximumgrowth in
that niche. In addition, it appears that E. coliMG1655 mot-1 also
uses galactose to colonize a second smaller intestinal niche that E.
coliMG1655 flhD either fails to colonize or colonizes poorly.
E. coli MG1655 forms mixed biofilms in the mouse intestine.
Commensal E. coli strains colonize the streptomycin-treated
mouse intestine by growing in the intestinal mucus layer of the
large intestine (39, 45, 46, 48, 59, 60, 65). It has recently become
clear that biofilms form in the mucus layers of the large intestines
of humans, rats, baboons, and mice (49, 61) and that mixed bio-
films consisting of bacteroides, enterobacter, and clostridium spe-
cies form rapidly on strands of mucin in mucus introduced into a
growing human microbiota contained in a continuous flow cul-
ture system constructed to mimic the human intestine (41).
Moreover, the kinetics of plasmid transfer between E. coli strains
in the streptomycin-treated mouse intestine suggests that E. coli
resides in biofilms in vivo (38). Previously, we reported that E. coli
MG1655 is found in cecal mucus dispersed as either single cells or
dividing doublets among othermembers of themicrobiota at 24 h
postfeeding (45, 46); however, in view of the recent data on bio-
film formation in themammalian intestine, wewonderedwhether
dense microbial communities containing E. coli MG1655 might
form in the streptomycin treatedmouse intestine at later times. As
shown previously and in Fig. 6A, at 24 h postfeeding E. coli
MG1655 appeared to be randomly dispersed and yet closely asso-
ciated with other members of the microbiota in the cecal mucus
layer; however, at 48 h postfeeding, although E. coli MG1655 re-
mained mostly as single cells or as doublets, they appeared to be
TABLE 5 Growth of MG1655 strains in cecal mucus in vitroa
Carbon source (cecal
mucus sample)









1 0.037 0.002 0.038 0.0006 0.045 0.0006 0.037 0.003 ND
2 ND 0.032 0.002 0.037 0.002 ND 0.028 0.001
a Cultures were grown overnight in LB broth Lennox, washed in HEPES-Hanks buffer (pH 7.0), used to inoculate 1 ml of cecal mucus (2.5 mg/ml) in HEPES-Hanks buffer, and
then incubated at 37°C in polystyrene cuvettes. The A600 of each culture was determined at 30-min intervals. The results of independent experiments (n 3) are shown.
b Cecal mucus cultures grew linearly. The slope of the line was used to measure the growth rate.
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minority members of dense mixed biofilms (Fig. 6B). At neither
24 h nor 48 h postfeeding was E. coliMG1655 found to be associ-
ated with the epithelium (Fig. 6).
DISCUSSION
Previously, we reported that the streptomycin-treated mouse in-
testine selects nonmotile E. coli MG1655 flhDC deletion mutants
that have improved colonizing ability (24, 36). These mutants
grew 15% faster than their parent in mouse cecal mucus in vitro
and 15 to 30% faster on several sugars found in the mouse intes-
tine, suggesting that their better colonizing ability was due to their
more efficient utilization of sugars for growth (36). In our previ-
ous studies, despite the strong selection for nonmotile flhDC de-
letion mutants, 10 to 20% of the E. coli MG1655 cells remained
motile (24). In the present study,we demonstrate that thesemotile
E. coli MG1655 contain missense mutations in envZ that make
them less motile and better colonizers than wild-type E. coli
MG1655 and more resistant to bile salts and colicin V than E. coli
MG1655 and E. coli MG1655 flhD, suggesting that they have
higher levels of OmpRP.
Among the many activities controlled by EnvZ/OmpR is tran-
FIG 4 Colonization of the mouse intestine by E. coli MG1655 mot-1, E. coli
MG1655mot-1 restored to wild type, E. coliMG1655mot-1galK, and E. coli
MG1655 flhD. Two sets of three mice were fed 1010 CFU of E. coli MG1655
mot-1 Strr (Œ) and 105 CFU of MG1655 Strr flhD::cat () (A); two sets of
three mice were fed 1010 CFU of E. coli MG1655 mot-1 Strr restored to wild
type (Œ) and 105 CFU of E. coliMG1655 StrrflhD::cat () (B); and three sets
of three mice were fed 1010 CFU of E. coliMG1655 mot-1 Strr galK () and
105 CFUof E. coliMG1655 StrrflhD::cat () (C). At the indicated times, fecal
samples were homogenized, diluted, and plated as described in Materials and
Methods. When necessary, i.e., to distinguish strains, 100 colonies from plates
containing streptomycin were toothpicked onto MacConkey agar plates con-
taining streptomycin and chloramphenicol. Bars represent standard errors of
the log10 means of CFU per g of feces.
FIG 5 Colonization of the mouse intestine by E. coli MG1655 mot-1, E. coli
MG1655 mot-1 galK, and E. coli MG1655 flhD. Three sets of three mice
were fed 1010 CFU of E. coliMG1655 StrrflhD::cat (Œ) and 105 CFU of E. coli
MG1655 mot-1 Strr Nalr () (A) and 1010 CFU of E. coli MG1655 Strr flhD
() and 105 CFU of E. coli MG1655 mot-1 Strr galK::cat (Œ) (B). At the
indicated times, fecal samples were homogenized, diluted, and plated as de-
scribed in Materials and Methods. Bars represent standard errors of the log10
means of CFU per g of feces.
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scription of the flhDC operon, i.e., OmpRP is a negative regula-
tor of the operon in E. coli strains that lack the IS1 element in the
flhDC promoter (56). Such strains are not hypermotile and be-
come even less motile at higher medium osmolarity because the
level of OmpRP under these conditions is sufficient to further
repress the flhDC operon (4, 24). In contrast, E. coli MG1655,
which contains the IS1 element in the flhDC promoter, remains
hypermotile under high-osmolarity conditions (4, 24), suggesting
the possibility that the IS1 element reduces the affinity of
OmpRP for theOmpRbinding sites in the flhDC promoter. The
fact that the E. coli MG1655 envZ missense mutants are far less
motile than E. coliMG1655 (Table 3) suggests that the even higher
level of OmpRP in thesemutants allows some level of binding to
the OmpR binding sites in the flhDC regulatory region, resulting
in less transcription of the operon and consequently less FlhD4C2,
despite the presence of the IS1 element. Also, since FlhD4C2 re-
presses a number of sugar catabolism operons (20), less FlhD4C2
in E. coliMG1655mot-1 than in E. coliMG1655 but more than in
E. coli MG1655 flhD would be consistent with it growing faster
than E. coliMG1655 on a number of sugars and slower than E. coli
MG1655 flhD on a number of sugars, as we observed (Table 4).
Although E. coli MG1655 mot-1 grew slower than E. coli
MG1655flhD on several sugars, it did grow ca. 30% faster thanE.
coliMG1655 flhD and E. coliMG1655 on galactose in vitro (Ta-
ble 4). In this regard, it is interesting that there is a putative OmpR
binding site upstream of the galR promoter between galR and
omrB (26). GalR is themajor repressor of both galactose transport
and catabolism (67). Although it is known that OmpRP posi-
tively regulates transcription of omrB (26), it is not known
whether it also negatively regulates galR transcription. Negative
regulation of galR transcription by increased levels ofOmpRP in
E. coliMG1655mot-1 could explainwhy it grows faster thanE. coli
MG1655 and E. coliMG1655flhD on galactose as the sole source
of carbon and energy.
Giraud et al. (25) demonstrated that when germfree mice were
fed the same wild-type E. coli MG1655 strain as used here, the
mouse intestine selected better-colonizing, less-motile E. coli
MG1655 envZ missense mutants. More recently, De Paepe et al.
(14) demonstrated that several days after the envZ missense mu-
tants reached maximum numbers in germfree mice monoassoci-
ated with E. coliMG1655, mutants with flhDC deletions appeared
and increased in numbers thereafter, showing that the monoasso-
ciated mouse intestine can select E. coli MG1655 flhDC deletion
mutants in the presence of high numbers of E. coliMG1655 envZ
missense mutants. Interestingly, our data show that the mono-
associated ex-germfree mouse intestine and the streptomycin-
treatedmouse intestine are different in this regard: flhDCmutants
would not be selected after envZ missense mutants reach maxi-
mum numbers in the streptomycin-treated mouse intestine since
in this model high numbers of an E. coli MG1655 envZ missense
mutant prevented growth of an E. coli MG1655 flhDC deletion
mutant from lower to higher numbers (Fig. 4A).
It was also demonstrated by De Paepe et al. (14) that their in
vivo results could be reproduced in chemostats containing 0.8%
bile salts, a concentration reasonable for the intestine of a germ-
free mouse (18), but 2.7-fold higher than the 0.3% concentra-
tion of bile salts reported to be in the human small intestine (64).
In fact, the presence of a conventional microbiota decreases the
concentration of bile salts in the mouse intestine, i.e., in the con-
ventionalmouse cecum and colon the concentration of bile salts is
known to be2.5-fold lower than in the germfree mouse cecum
and colon (18). It is therefore unlikely that bile salts play as much
of a role in E. coli MG1655 colonization of the streptomycin-
treatedmouse intestine, which contains a large and diversemicro-
biota, as they do in its colonization of the monoassociated mouse
intestine. In support of this view, despite E. coli MG1655 flhD
being more sensitive to bile salts than E. coli MG1655 mot-1, the
two strains grew equally well from low to high numbers in the
streptomycin treated mouse intestine when 105 CFU each of
the two strains were fed tomice simultaneously (Fig. 3B). It there-
fore appears likely that the differences between our results and
those of De Paepe et al. (14) reflect physical and nutritional inter-
action of the E. coli MG1655 strains with other members of the
complex microbial community present in the streptomycin-
treated mouse intestine but absent in the monoassociated, for-
merly germfree mouse intestine.
The concept that nutrient availability dictates the community
structure of the intestine was originally presented in Freter’s nu-
trient-niche hypothesis, which states that species coexist in the
intestine because each is able to grow faster than all others on one
FIG 6 In situ hybridization with fluorescence-labeled oligonucleotide probes. At 24 and 48 h postfeeding, cecal mucosal sections of mice fed E. coliMG1655 Strr
were hybridized with an E. coli-specific oligonucleotide probe (red) and a eubacterium-specific oligonucleotide probe (green). EP, epithelium. E. coli cells appear
red, while all other bacteria appear green. Bars, 16 m. (A) 24 h postfeeding; (B) 48 h postfeeding.
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or a few limiting nutrients and that the rate of growth of each
species during the colonization process is at least equal to its wash-
out rate from the intestine (22). The hypothesis assumes that all
nutrients are perfectly mixed and that they are equally available to
all species present in the intestine. According to the hypothesis,
two strains cannot coexist in the intestine when one competes
less well than the other for the same nutrient(s) unless the
metabolically less efficient one adheres to the intestinal wall
(22). Adhesion of a bacterium to the intestinal wall is not re-
stricted to the epithelium, it could, for example, also be
achieved by adhesion of that bacterium to mucin strands in the
outer loose mucus layer where commensal strains reside (32,
50) that might be anchored in the relatively bacteria-free inner
dense mucus layer or, alternatively by attachment to other
members of the microbiota that adhere to mucin strands in the
outer loose mucus layer. In either case, such attachment could
delay the metabolically less efficient strain from being washed
out as the loose mucus layer at the luminal surface is sloughed
into luminal contents and eliminated in feces.
We found no evidence that E. coli MG1655 adheres to the in-
testinal epithelium but did find that it binds to other members of
the microbiota as a minority member of mixed biofilms in cecal
mucus (Fig. 6B). We also found that E. coliMG1655mot-1 and E.
coli MG1655 flhD each use some sugars for growth better than
the other in vitro (Table 4) and that they cocolonize the mouse
intestine equally well when equal numbers of each strain are fed to
mice (Fig. 3B), indicating that sufficient levels of the sugars that
each strain uses better are available to each strain when they co-
colonize. As such, it would be expected according to the nutrient-
niche hypothesis that low numbers of each strain would be able to
grow to higher numbers in the intestine in the presence of high
numbers of the other strain. Indeed, by using its superior ability to
grow on galactose, low numbers of E. coliMG1655 mot-1 grew to
higher numbers in the presence of high numbers of E. coli
MG1655flhD (Fig. 5A).However, contrary to expectations, high
numbers of E. coli MG1655 mot-1 prevented low numbers of E.
coli MG1655 flhD from growing to higher numbers (Fig. 4A).
Below we outline a modified version of the Freter nutrient-niche
hypothesis to explain our results based on the finding that E. coli
MG1655 appears to reside in mixed biofilms in the streptomycin-
treated mouse intestine.
Mono- and disaccharides and maltodextrins are absorbed in
the small intestine, whereas dietary fiber reaches the large intestine
intact. In contrast to the anaerobes (29), E. coli does not secrete
extracellular polysaccharide hydrolases (27, 30) and therefore
cannot degrade dietary fiber-derived and mucin-derived oligo-
and polysaccharides. Commensal E. coli strains colonize the
mouse large intestine by growing in intestinal mucus (39, 45, 46,
48, 59, 60, 65). It therefore appears likely that E. coli depends on
the anaerobes present in mucus that can degrade oligo- and poly-
saccharides to provide them with the mono-and disaccharides
they need for growth. We hypothesize that the anaerobes in the
mixed biofilms inhabited by E. coli provide them with mono- and
disaccharides locally, rather than from a perfectly mixed pool
available to all species, which is an assumption of the nutrient-
niche hypothesis. We further hypothesize that one strain of E. coli
can have a higher affinity for binding sites onmixed biofilms than
a second strain due to differences between the outer surfaces of the
two strains. In addition, we hypothesize that E. coli cells that de-
tach from a mixed biofilm either spontaneously or through repli-
cation and hence free in mucus are not exposed to mono- and
disaccharides because those sugars are produced and used locally
within the mixed biofilms and are therefore not available to de-
tached E. coli cells. Consequently, E. coli cells not attached to a
mixed biofilm will not grow or will grow slower than the washout
rate andwill be eliminated in feces unless they bind to and become
part of other mixed biofilms that are constantly forming in the
mucus layer.
How does the hypothesis account for our results? Our re-
sults suggest that the outer membranes of E. coli MG1655
mot-1 and E. coliMG1655 flhD differ not only with respect to
the presence or absence of flagella and amounts of OmpF and
OmpC but also with respect to the amounts of a number of
proteins present in their outer membranes, including CirA and
CsgD (see Results and reference 26), which we hypothesize
results in E. coliMG1655 mot-1 having a higher affinity than E.
coli MG1655 flhD for the E. coli binding sites on the mixed
biofilms they inhabit. In addition, E. coliMG1655 mot-1 grows
slower than E. coli MG1655 flhD on a number of sugars pres-
ent in mucus and in mouse cecal mucus in vitro (Table 5).
Accordingly, we suggest that the lower growth rate of E. coli
MG1655 mot-1 within a biofilm is compensated for by its
higher affinity for the biofilm. If so, it would then be expected
that if E. coliMG1655mot-1 and E. coliMG1655flhDwere fed
to mice in equal numbers they would cocolonize in about equal
numbers, as observed (Fig. 3B), and if mice were fed E. coli
MG1655 mot-1 and E. coli MG1655 flhD at a ratio of 105:1,
that ratio would also be maintained throughout the duration of
the experiment, as observed (Fig. 4A). However, it would also
be expected that if mice were fed E. coli MG1655 flhD and E.
coli MG1655 mot-1 at a ratio of 105:1, that ratio would be
maintained throughout the duration of the experiment, when
in fact, under these conditions, low numbers of E. coliMG1655
mot-1 grow to higher numbers (Fig. 5A). This can be explained
if E. coliMG1655 mot-1 also grows in a second niche that E. coli
MG1655 flhD cannot colonize or colonizes poorly. That sec-
ond niche could be another mixed biofilm consisting of a dif-
ferent group of anaerobes in which E. coliMG1655 mot-1 takes
advantage not only of its higher affinity for binding sites but
also of its superior growth rate on galactose and thereby pre-
vents E. coli MG1655 flhD from occupying that niche. Alter-
natively, that second niche could be another mixed biofilm that
contains an anaerobe that makes a bacteriocin that inhibits E.
coli MG1655 flhD growth far more than it inhibits E. coli
MG1655 mot-1 growth, much in the same way that E. coliMG1655
flhD ismore sensitive to colicinV thanE. coliMG1655mot-1.Most
bacterial species, including several that reside in the mammalian in-
testine, are known to make bacteriocins, many of which kill across
species (54). Finally, our hypothesis raises the possibility that E. coli
strains with vastly different surfaces (e.g., fimbriae, O, K, andH anti-
gensetc) reside inbiofilmsmadeupofdifferentanaerobes that supply
different sugars to those strains, which could explainwhy differentE.
coli strains display different nutritional programs in the intestine (19,
35).Whetherourhypothesis,whichwe call the “Restaurant”hypoth-
esis, has merit will be the focus of future research.
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